Lipid Phase Organization Controls Drug Partitioning and Release Across Lipid Nanocarriers

Abstract

Understanding how lipid organization governs drug incorporation and release across nanocarrier platforms remains a central challenge in the rational design of lipid-based delivery systems. Here, lipid nanoparticles (LNP), liposomes (LIP), solid lipid nanoparticles (SLN), and nanostructured lipid carriers (NLC) were systematically compared to establish direct relationships between lipid composition, local structural order, and release behavior. Dexamethasone was employed as a model lipophilic probe to investigate molecular partitioning across these distinct lipid environments. Nanocarriers were characterized in terms of size, polydispersity, zeta potential, encapsulation efficiency (EE), and drug loading (DL), while lipid dynamics were resolved by spin-label electron spin resonance (ESR) using depth-sensitive probes. In vitro release profiles were obtained at 4 and 37 °C to evaluate temperature-dependent permeability. SPC-based liposomes exhibited the highest incorporation (EE ≈ 90%; DL ≈ 45 µmol/mol) and the lowest motional restriction, as indicated by reduced rotational correlation times and 2A|| values, and displayed the slowest release kinetics. In contrast, HSPC-based liposomes generated the most ordered lipid environments, with the highest ESR-derived motional parameters, exceeding those observed for SLN and LNP, and showed rapid release at 37 °C but strong retention at 4 °C, indicating pronounced thermal sensitivity. SLN, NLC, and LNP exhibited lower incorporation (EE < 35%) and intermediate motional restriction, converging toward less favorable environments for drug accommodation despite their distinct supramolecular structures. Across all systems, encapsulation and release behavior correlated consistently with ESR-derived descriptors of lipid mobility and order rather than with nanocarrier class. These findings demonstrate that the physicochemical state of the lipid phase-defined by composition, packing, and dynamic heterogeneity-governs molecular accommodation and diffusion. This work establishes a direct experimental framework linking lipid organization to functional performance and provides quantitative descriptors to guide the rational design of lipid nanocarriers beyond conventional structural classification.

Supplementary files

Article information

Article type
Paper
Submitted
17 Apr 2026
Accepted
23 Jun 2026
First published
24 Jun 2026
This article is Open Access
Creative Commons BY-NC license

RSC Pharm., 2026, Accepted Manuscript

Lipid Phase Organization Controls Drug Partitioning and Release Across Lipid Nanocarriers

J. Pires, L. R. De Souza, B. B. Fontanezi, S. Mendanha and E. Lima, RSC Pharm., 2026, Accepted Manuscript , DOI: 10.1039/D6PM00126B

This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. You can use material from this article in other publications, without requesting further permission from the RSC, provided that the correct acknowledgement is given and it is not used for commercial purposes.

To request permission to reproduce material from this article in a commercial publication, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party commercial publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements